Earlier quoted context omitted.
> In a normal market situation, prices are determined by supply and demand. But that's really not such a situation here. Isn't it exactly the situation here? I mean, a few months ago we even had central governments bid against their own local governments to have access to vaccines. Doesn't that lay out quite clearly that this is a demand-driven market?
The market is not normal because countries have invested massive sums of money into these companies without acquiring shares in return, so I just hope they have negotiated other terms to get the vaccines at fair prices.
I don't believe this is a fair or accurate description of what really happens.
Countries invest in education and free and open research, countries invest in entrepreneurship and in people launching startups, and countries invest in partnerships between their public research and private companies to foster the creation of added-value products and services.
And in the end those companies pay taxes back to the state, which in Europe (where BioNTech is from) is higher than 20%.
Furthermore, your comment has nothing at all to do with markets. You're trying to pin onto the "market" tag one of the most basic characteristics of social democratic societies, where the state invests in infrastructure and in lowering or eliminating barriers to entry in business.